An article in the June issue (Nat. Biotechnol. 22, 773–774, 2004) highlights the challenge of producing a shared vocabulary that biologists can use to communicate their results effectively ...

In a significant breakthrough, researchers have developed COVID-19 eliminative Short Peptide Inhibiting ACE2 binding (CeSPIACE), a mutation-tolerant spike protein inhibitor that remains effective ...

has developed COVID-19 eliminative Short Peptide Inhibiting ACE2 binding (CeSPIACE), a mutation-tolerant spike protein inhibitor that remains effective against SARS-CoV-2 variants, including ...